NG
IBB icon

NatWest Group’s iShares Biotechnology ETF IBB Stock Holding History

NatWest Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-102,261
Closed -$10.3M – 220
2015
Q3 		$10.3M Sell
102,261
-20,358
-17% -$2.44M 0.23% 52
2015
Q2 		$15.1M Buy
122,619
+16,542
+16% +$1.98M 0.19% 32
2015
Q1 		$12.1M Sell
106,077
-17,874
-14% -$1.97M 0.16% 46
2014
Q4 		$12.5M Sell
123,951
-12,996
-9% -$1.26M 0.11% 44
2014
Q3 		$12.5M Buy
136,947
+25,047
+22% +$2.2M 0.11% 50
2014
Q2 		$9.59M Sell
111,900
-70,173
-39% -$5.53M 0.4% 73
2014
Q1 		$14.3M Sell
182,073
-6,057
-3% -$505K 0.64% 41
2013
Q4 		$14.2M Buy
188,130
+5,622
+3% +$399K 0.36% 66
2013
Q3 		$12.8M Buy
182,508
+3,702
+2% +$243K 0.37% 61
2013
Q2 		$10.4M Buy
+178,806
New +$10.3M 0.15% 115

Other funds holding IBB

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

NatWest Group's IBB Position: Q4 2015 in Review

NatWest Group sold out of iShares Biotechnology ETF (IBB) in Q4 2015, closing a stake of 102,261 shares — an estimated $10.3M sold.

NatWest Group first reported a position in IBB in Q2 2013 and held it in 10 quarters. The position peaked at $15.1M in Q2 2015. 432 funds tracked by Wall St. Rank hold IBB as of Q4 2015.

  • NatWest Group reported no remaining iShares Biotechnology ETF position as of Q4 2015 after selling out during the quarter.
  • NatWest Group sold 102,261 iShares Biotechnology ETF shares in Q4 2015, an estimated $10.3M.
  • NatWest Group first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 10 quarters.
  • NatWest Group's iShares Biotechnology ETF position peaked at $15.1M in Q2 2015.
  • 432 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2015.

Based on NatWest Group's 13F filing for Q4 2015, filed 16 Feb 2016.